IDEXX LABORATORIES INC /DE (IDXX) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 1048 transactions totaling $558.0M, demonstrating a bearish sentiment with -$558.0M in net insider flow. The most recent transaction on Nov 7, 2025 involved a sale of 5,114 shares valued at $3.6M.
No significant insider buying has been recorded for IDXX in the recent period.
No significant insider selling has been recorded for IDXX in the recent period.
Based on recent SEC filings, insider sentiment for IDXX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$558.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IDEXX LABORATORIES INC /DE (IDXX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading IDXX stock, having executed 1048 transactions in the past 90 days. The most active insider is Jonathan W. Ayers (Executive), who has made 258 transactions totaling $246.0M.
Get notified when executives and directors at IDXX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Hunt Nimrata | Executive | Sale | 5,114 | $702.20 | $3.6M | Large |
| Nov 7, 2025 | Hunt Nimrata | Executive | Option Exercise | 5,405 | $505.53 | $2.7M | Large |
| Nov 7, 2025 | Hunt Nimrata | Executive | Option Exercise | 7,125 | $288.78 | $2.1M | Large |
| Nov 7, 2025 | Hunt Nimrata | Executive | Sale | 1,378 | $705.54 | $972.2K | Large |
| Nov 7, 2025 | Hunt Nimrata | Executive | Sale | 1,468 | $704.87 | $1.0M | Large |
| Nov 7, 2025 | Hunt Nimrata | Executive | Sale | 1,465 | $703.73 | $1.0M | Large |
| Oct 30, 2025 | L. Hooley Joseph | Executive | Award | 39 | $628.54 | $24.5K | |
| Sep 1, 2025 | Alexander Smith Martin | Executive | Option Exercise | 18 | $N/A | $0 | |
| Sep 1, 2025 | Alexander Smith Martin | Executive | Payment | 5 | $647.09 | $3.2K | |
| Aug 22, 2025 | Anne Szostak M. | Executive | Sale | 2,187 | $647.33 | $1.4M | Large |
| Aug 22, 2025 | Anne Szostak M. | Executive | Option Exercise | 2,187 | $206.62 | $451.9K | |
| Aug 22, 2025 | Anne Szostak M. | Executive | Gift | 259 | $N/A | $0 | |
| Aug 22, 2025 | Anne Szostak M. | Executive | Gift | 259 | $N/A | $0 | |
| Aug 15, 2025 | Jay Mazelsky Jonathan | Executive | Gift | 1,051 | $N/A | $0 | |
| Aug 12, 2025 | E. Underberg Sharon | Executive | Option Exercise | 183 | $544.08 | $99.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 474 | $558.0M | 83.0% |
Exercise(M) | 389 | $91.4M | 13.6% |
Payment(F) | 60 | $22.3M | 3.3% |
Award(A) | 41 | $541.4K | 0.1% |
Gift(G) | 84 | $0 | 0.0% |
Insider selling pressure at IDEXX LABORATORIES INC /DE has increased, with 26 insiders executing 1048 transactions across all time. Total sales of $558.0M significantly outpace purchases of $0, resulting in a net outflow of $558.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.